FBR Capital initiated coverage on TherapeuticsMD Inc. (NYSE:TXMD) with a Outperform rating and a price target of $34. TherapeuticsMD Inc. (NYSEMKT:TXMD) weekly performance is 23.76%. On last trading day company shares ended up $5.47. Analysts mean target price for the company is $9.40. TherapeuticsMD Inc. (NYSEMKT:TXMD) distance from 50-day simple moving average (SMA50) is 28.96%.
Ladenburg Thalmann Financial Services (NYSEMKT:LTS)’s Director, Saul Gilinski purchased 60,000 shares of Common Stock, directly, on 30 June. The insider purchase was executed in two steps, buying 50,000 shares for a price of $3.15 per share and then another 10,000 shares for $3.12 per share. Ladenburg Thalmann Financial Services (NYSEMKT:LTS) shares advanced 7.63% in last trading session and ended the day on $3.81. LTS gross Margin is 27.70% and its return on assets is -1.80%.Ladenburg Thalmann Financial Services (NYSEMKT:LTS) quarterly performance is 36.07%.
Ophthotech Corp (NASDAQ:OPHT) CFO Bruce Peacock sold 7,739 shares of the stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $41.07, for a total transaction of $317,840.73. Ophthotech Corp (NASDAQ:OPHT) shares moved up 5.78% in last trading session and was closed at $41.92, while trading in range of $39.22 – $41.98. Ophthotech Corp (NASDAQ:OPHT) year to date (YTD) performance is 29.58%.
On July 2, 2014, China Biologic Products, Inc. (NASDAQ:CBPO) completed an offering (the “Offering”) of 1,782,500 shares of its common stock at a price of $38.00 per share, less the underwriting discounts. In the Offering, the Company sold 920,000 shares (including 120,000 shares sold pursuant to the exercise by the underwriters of their option to purchase additional shares from the Company) and a selling stockholder sold 862,500 shares (including 112,500 shares sold pursuant to the exercise by the underwriters of their option to purchase additional shares from such selling stockholder). China Biologic Products Inc. (NASDAQ:CBPO) ended the last trading day at $49.58. Company weekly volatility is calculated as 9.22% and price to cash ratio as 15.49.China Biologic Products Inc. (NASDAQ:CBPO) showed a positive weekly performance of 11.49%.